Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease ...Middle East

PR Newswire - News
Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease

PENNINGTON, N.J., March 12, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Illexcor Therapeutics (Illexcor), a pioneering biopharmaceutical company developing next-generation oral...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease )

    Apple Storegoogle play

    Also on site :